Hemetron enables quantitative at-home blood testing and remote monitoring for chronic diseases, starting with rheumatology.

We empower physicians to personalize treatment using accurate, quantitative self-tests, beginning with CRP for inflammatory conditions. Our platform brings lab-grade biomarker insights into patients’ homes, closing monitoring gaps that delay care and drive up costs.

Backed by leading clinicians, the Innosuisse Start-up Innovation Project grant and selected as a Venture Leader Medtech 2025, Hemetron is shaping the future of precision care, starting at home.

Hemetron

Org chart

Teams

Offices